NO20015247D0 - Glysinspaltingssysteminhibitorer som potensielle antipsykotika - Google Patents
Glysinspaltingssysteminhibitorer som potensielle antipsykotikaInfo
- Publication number
- NO20015247D0 NO20015247D0 NO20015247A NO20015247A NO20015247D0 NO 20015247 D0 NO20015247 D0 NO 20015247D0 NO 20015247 A NO20015247 A NO 20015247A NO 20015247 A NO20015247 A NO 20015247A NO 20015247 D0 NO20015247 D0 NO 20015247D0
- Authority
- NO
- Norway
- Prior art keywords
- glycemic
- system inhibitors
- antipsychotics
- potential
- potential antipsychotics
- Prior art date
Links
- 239000000164 antipsychotic agent Substances 0.000 title 1
- 229940005529 antipsychotics Drugs 0.000 title 1
- 230000002641 glycemic effect Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13164799P | 1999-04-29 | 1999-04-29 | |
| EP99108480 | 1999-04-30 | ||
| PCT/EP2000/003456 WO2000066110A1 (en) | 1999-04-29 | 2000-04-17 | Glycine cleavage system inhibitors as potential antipsychotics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20015247L NO20015247L (no) | 2001-10-26 |
| NO20015247D0 true NO20015247D0 (no) | 2001-10-26 |
Family
ID=56290006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20015247A NO20015247D0 (no) | 1999-04-29 | 2001-10-26 | Glysinspaltingssysteminhibitorer som potensielle antipsykotika |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6395780B1 (no) |
| EP (1) | EP1185259A1 (no) |
| JP (1) | JP2002543124A (no) |
| KR (1) | KR20020008167A (no) |
| AU (1) | AU4748100A (no) |
| BR (1) | BR0010151A (no) |
| CA (1) | CA2372073A1 (no) |
| CZ (1) | CZ20013786A3 (no) |
| MX (1) | MXPA01010933A (no) |
| NO (1) | NO20015247D0 (no) |
| PL (1) | PL353180A1 (no) |
| WO (1) | WO2000066110A1 (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004041151A2 (en) * | 2002-11-07 | 2004-05-21 | Technion Research And Development Foundation Ltd. | Neuroprotective iron chelators and pharmaceutical compositions comprising them |
| GB2398497A (en) * | 2003-02-19 | 2004-08-25 | Walcom Animal Science | Composition for improving immunity of animals |
| JPWO2004093910A1 (ja) * | 2003-04-22 | 2006-07-13 | アステラス製薬株式会社 | ＰＰＡＲδアゴニストによる脳神経変性疾患治療剤 |
| CN1867324A (zh) * | 2003-10-15 | 2006-11-22 | 前体生物药物股份公司 | 谷氨酰胺酰基环化酶效应物和谷氨酸环化酶效应物的应用 |
| US8097608B2 (en) * | 2003-11-25 | 2012-01-17 | Technion Research And Development Foundation Ltd. | Methods for treatment of cardiovascular disorders and diseases |
| EP2433626B1 (en) | 2003-11-25 | 2015-11-04 | Technion Research & Development Foundation Ltd. | Compositions and methods for treatment of cardiovascular disorders and diseases |
| CA2592631A1 (en) * | 2003-12-29 | 2005-07-21 | Jason Mcdevitt | Compositions and methods to treat recurrent medical conditions |
| TW200528090A (en) * | 2004-01-13 | 2005-09-01 | Omega Bio Pharma I P 2 Ltd | Methods for treating stress and affecting biological immune systems |
| JP2005232148A (ja) * | 2004-02-03 | 2005-09-02 | Technion Research & Development Foundation Ltd | 神経保護剤としてプロパルギルアミンの使用 |
| WO2005094897A2 (en) | 2004-04-01 | 2005-10-13 | Cardiome Pharma Corp. | Pegylated ion channel modulating compounds |
| ITMI20040876A1 (it) * | 2004-04-30 | 2004-07-30 | Univ Degli Studi Milano | Inibitori delle istone deacetilasi-hdac-quali agenti ipolipidemizzati per la terapia e la prevenzione dell'arteriosclerosi e malattie cardiovascolari |
| AU2006251832A1 (en) * | 2005-05-27 | 2006-11-30 | Queen's University At Kingston | Treatment of protein folding disorders |
| FR2890563B1 (fr) * | 2005-09-09 | 2007-10-19 | Servier Lab | Nouvelle association entre l'agomelatine et un agent thymoregulateur et les compositions pharmaceutiques qui la contiennent |
| US8263655B2 (en) | 2005-10-06 | 2012-09-11 | Technion Research And Development Foundation Ltd | Methods for treatment of renal failure |
| KR200453511Y1 (ko) * | 2009-12-29 | 2011-05-13 | 한국강성(주) | 마이크로 유에스비 커넥터 플러그 |
| RU2607595C2 (ru) | 2010-02-03 | 2017-01-10 | Фарма Ту Б Лтд. | Составы разагилина с пролонгированным высвобождением и их применение |
| JP2015509489A (ja) | 2012-02-10 | 2015-03-30 | ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ | がんの処置のためのグリシン開裂系の阻害 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9218709D0 (en) * | 1992-09-04 | 1992-10-21 | Salim Aws S M | Biologically active health formulation |
| AU3470399A (en) * | 1998-03-30 | 1999-10-18 | Endowment for Research in Human Biology, Inc., The | Agents and methods for modulation of zinc transfer by metallothionein |
-
2000
- 2000-04-17 PL PL00353180A patent/PL353180A1/xx unknown
- 2000-04-17 MX MXPA01010933A patent/MXPA01010933A/es unknown
- 2000-04-17 JP JP2000614995A patent/JP2002543124A/ja active Pending
- 2000-04-17 WO PCT/EP2000/003456 patent/WO2000066110A1/en not_active Ceased
- 2000-04-17 AU AU47481/00A patent/AU4748100A/en not_active Abandoned
- 2000-04-17 KR KR1020017013838A patent/KR20020008167A/ko not_active Withdrawn
- 2000-04-17 CA CA002372073A patent/CA2372073A1/en not_active Abandoned
- 2000-04-17 EP EP00929364A patent/EP1185259A1/en not_active Withdrawn
- 2000-04-17 CZ CZ20013786A patent/CZ20013786A3/cs unknown
- 2000-04-17 BR BR0010151-6A patent/BR0010151A/pt not_active Application Discontinuation
- 2000-04-28 US US09/559,831 patent/US6395780B1/en not_active Expired - Fee Related
-
2001
- 2001-10-26 NO NO20015247A patent/NO20015247D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1185259A1 (en) | 2002-03-13 |
| NO20015247L (no) | 2001-10-26 |
| PL353180A1 (en) | 2003-11-03 |
| CA2372073A1 (en) | 2000-11-09 |
| US6395780B1 (en) | 2002-05-28 |
| JP2002543124A (ja) | 2002-12-17 |
| MXPA01010933A (es) | 2002-06-21 |
| CZ20013786A3 (cs) | 2002-02-13 |
| AU4748100A (en) | 2000-11-17 |
| WO2000066110A1 (en) | 2000-11-09 |
| KR20020008167A (ko) | 2002-01-29 |
| BR0010151A (pt) | 2002-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20015065D0 (no) | Pyrazolobenzodiazepiner som CDK2-inhibitorer | |
| DK1244647T3 (da) | Quinzolinderivater som VIGF-inhibitorer | |
| DK2253620T3 (da) | Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer | |
| NO20021239L (no) | Pteridinoner som kinase-inhibitorer | |
| NO20031006L (no) | Imidazolo-5-yl-2-anilino-pyrimidiner som midler for inhibering av celleproliferasjon | |
| EE200100492A (et) | Ensüümi IMPDH inhibiitorid | |
| PT1181017E (pt) | Inibidores de metaloproteases | |
| DE60020763D1 (de) | Sterilisationssystem | |
| DK1526134T3 (da) | Triazolyltropanderivater som CCR5-modulatorer | |
| NO20015247D0 (no) | Glysinspaltingssysteminhibitorer som potensielle antipsykotika | |
| PT1194404E (pt) | Inibidores de aspartil-protease | |
| NO20016201D0 (no) | Tienopyrimidiner som fosfodiesteraseinhibitorer | |
| DK1144431T3 (da) | 16-Hydroxyestratriener som selektivt aktive estrogener | |
| NO20014875L (no) | Promedikamenter for trombin inhibitorer | |
| NO20021959D0 (no) | Tetrahydrotiopyranftalazinon-derivater som PDE4-inhibitorer | |
| DE60024101D1 (de) | Enzyminhibitoren | |
| NO20000094D0 (no) | 6-Azaurcilderivater som IL-5 inhibitorer | |
| DK1020430T3 (da) | Middel indeholdende L-carnitin | |
| DK1380585T3 (da) | Pyrazolopyridinon som mellemprodukt | |
| NO20020592D0 (no) | Fluorenderivater som integrininhibitorer | |
| DK1181271T3 (da) | Naphthalenurinstoffer som inhibitorer af glucoseoptagelse | |
| IT1311599B1 (it) | Scopa particolarmente per esterni. | |
| CA85567S (fr) | Bouteille | |
| UA3115S (uk) | Пляшка | |
| UA3297S (uk) | Пляшка |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |